Cybersecurity in Artificial Pancreas Experiments.
Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.
1 Division of Endocrinology, Mayo Clinic , Rochester, Minnesota.
Derek T
DT
O'Keeffe
1 Division of Endocrinology, Mayo Clinic , Rochester, Minnesota.
Spyridoula
S
Maraka
1 Division of Endocrinology, Mayo Clinic , Rochester, Minnesota.
Ananda
A
Basu
2 Center for Diabetes Technology, University of Virginia , Charlottesville, Virginia.
Patrick
P
Keith-Hynes
1 Division of Endocrinology, Mayo Clinic , Rochester, Minnesota.
Yogish C
YC
Kudva
D016494:Computer Security; D003920:Diabetes Mellitus / Q000628:therapy; D006801:Humans; D019397:Pancreas, Artificial / Q000592:standards*